Mindfulness meditation for younger breast cancer survivors: testing digital interventions in clinical and community settings

Active Project Grant Awarded Last action

Award ID
R01CA282416
Recipient
Awarding agency
Obligated
$2,218,282

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date 51% complete
Place of performance
Los Angeles, CA 90095, USA

Award details come from USAspending.gov.

Description

Abstract
Breast cancer is the most common cancer in younger women (≤ 50 years at time of diagnosis), who comprise approximately 19% of incident breast cancer cases. Improved survival after a breast cancer diagnosis has focused attention on the impact of the disease and its treatments on long-term outcomes in younger women. Studies have consistently shown that younger women have greater psychological and physical morbidity after breast cancer than older women and age-matched women with no cancer history, including elevated levels of depression. Depression has been linked to treatment non-adherence and predicts shorter recurrence-free and overall survival in women with breast cancer, highlighting its clinical relevance. Younger breast cancer survivors also report high levels of fatigue, insomnia, vasomotor symptoms, and cancer-related stress that may persist for years after diagnosis, causing significant impairment in quality of life. There is a critical need for effective, scalable interventions that can reduce depression and enhance long-term survivorship in this vulnerable group. To meet this need, we will conduct a phase III randomized clinical trial testing two new digital versions of a brief mindfulness intervention designed for younger breast cancer survivors. This study concept has been peer- reviewed and endorsed by the national cancer institute (NCI) and the NRG oncology national community oncology research program (NCORP) which will implement the study protocol through its network of community and clinical sites, ensuring a broad and diverse group of participants. The mindful awareness practices (MAPS) intervention has demonstrated efficacy in reducing depression and improving physical and psychological well- being in younger breast cancer survivors when delivered in person, in groups. We have developed and pilot tested two digital versions of the intervention, one delivered live online in groups over zoom with an experienced instructor (MAPS live online), and the other delivered via a professionally-produced APP (MAPS APP). We hypothesize that both digital interventions will be effective in reducing depressive symptoms (primary outcome) and improving physical and psychological symptoms and work productivity (secondary outcomes) at post- intervention and over a 6-month follow-up relative to a meditation only control group. In addition to testing efficacy, we will evaluate the cost-effectiveness of these programs, which is critical for payors to make coverage decisions, healthcare providers and employers to make adoption decisions, and patients to make participation decisions. We will also collect implementation data from study sites to inform future dissemination efforts. Finally, we will explore potential mediators and moderators of intervention effects to determine how these approaches work and for whom, which will facilitate targeted intervention delivery and content to those most likely to benefit.

Transactions

Action Obligated Date
Amendment $605,258
Amendment $582,216
Amendment $515,404
Original award $515,404

Subawards

Subrecipient Amount Awarded
NRG Oncology Foundation Inc. The NRG Oncology Statistical Data and Manageent Cernter (SDCM), residing within the University of Pittsburgh, will manage, oversee, and be responsible for the… $41,149
Eich Incorporated The digital therapeutic MAPs program will offer breast cancer survivors a convenient, accessible, and scientifically validated set of resources to learn and… $617,284

Quick answers

Who received award R01CA282416?

R01CA282416 was awarded to University Of California, LOS Angeles by National Cancer Institute (National Institutes of Health) on May 1, 2024.

How much is award R01CA282416 worth?

$2,218,282 has been obligated on R01CA282416.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award